Ads
-
Related paper
- Are Fludarabine Based Regimens Still Adequate for Relapsed/Refractory Follicular Lymphoma? An 18-Year Single-Center Experience
- Out-of-pocket costs analysis of ifosfamide, epirubicin, and etoposide (IEV) and etoposide, solu-medrol-methylprednisolone, high-dose ara-C-cytarabine, and platinol-cisplatin (ESHAP) regimens in the patients with relapsed and refractory lymphoma in Iran
- CRT-P Implantation and Consecutive AV-node Ablation as Rescue Therapy for Refractory Atrial Fibrillation: A Single Center Experience
- A Single Center 11 Year Experience with 202 Pancreas Transplants: Evolving Trends
- Are there any Dermoscopic Signs of Primary Cutaneous Follicular Center B-cell Lymphoma?
- Bacterial etiology and antimicrobial susceptibility profiles of 7741 urine cultures in outpatients: A 5-year single-center experience in Turkey
- TRANSFORMATION OF FOLLICULAR LYMPHOMA TO HODGKIN-LIKE LYMPHOMA: A CASE REPORT OF A DIAGNOSTIC PITFALL
- Immunoblastic morphology as a possible prognostic indicator for the outcome of the patients with diffuse large B cell lymphoma in era of the rituximab based treatment: single centre experience
- PERITONEAL DIALYSIS TECHNIQUE SURVIVAL: A SINGLE-CENTER EXPERIENCE ANALYSIS OF THE PERITONEAL DIALYSIS TREATMENT IN A SINGLE CENTER
- Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia